XML 37 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]
GEOVAX LABS, INC.
SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS
 
For the Years Ended
December 31, 2020
and
2019
 
           
Additions (Reductions)
                 
Description
 
Balance at
Beginning
Of Period
   
Charged to
Costs and
Expenses
   
Charged to
Other
Accounts
   
Deductions
   
Balance at
End
Of Period
 
Reserve Deducted in the Balance Sheet From the Asset to Which it Applies:
                                       
                                         
Allowance for Deferred Tax Assets
                                       
Year ended December 31, 2020
  $
18,787,230
    $
(2,811,563
)   $
-0-
    $
-0-
    $
15,975,667
 
Year ended December 31, 2019
   
19,879,954
     
(1,092,724
)    
-0-
     
-0-
     
18,787,230